These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 23806388)

  • 1. Do nomograms designed to predict biochemical recurrence (BCR) do a better job of predicting more clinically relevant prostate cancer outcomes than BCR? A report from the SEARCH database group.
    Teeter AE; Presti JC; Aronson WJ; Terris MK; Kane CJ; Amling CL; Freedland SJ
    Urology; 2013 Jul; 82(1):53-8. PubMed ID: 23806388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nomogram Predicting Prostate Cancer-specific Mortality for Men with Biochemical Recurrence After Radical Prostatectomy.
    Brockman JA; Alanee S; Vickers AJ; Scardino PT; Wood DP; Kibel AS; Lin DW; Bianco FJ; Rabah DM; Klein EA; Ciezki JP; Gao T; Kattan MW; Stephenson AJ
    Eur Urol; 2015 Jun; 67(6):1160-1167. PubMed ID: 25301759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are biochemical recurrence outcomes similar after radical prostatectomy and radiation therapy? Analysis of prostate cancer-specific mortality by nomogram-predicted risks of biochemical recurrence.
    Lee BH; Kibel AS; Ciezki JP; Klein EA; Reddy CA; Yu C; Kattan MW; Stephenson AJ
    Eur Urol; 2015 Feb; 67(2):204-9. PubMed ID: 25294696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postoperative prostate-specific antigen nadir improves accuracy for predicting biochemical recurrence after radical prostatectomy: Results from the Shared Equal Access Regional Cancer Hospital (SEARCH) and Duke Prostate Center databases.
    Moreira DM; Presti JC; Aronson WJ; Terris MK; Kane CJ; Amling CL; Sun LL; Moul JW; Freedland SJ
    Int J Urol; 2010 Nov; 17(11):914-22. PubMed ID: 20880361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re-calibration and external validation of an existing nomogram to predict aggressive recurrences after radical prostatectomy.
    Schroeck FR; Kattan MW; Moul JW; Aronson WJ; Presti JC; Terris MK; Kane CJ; Amling CL; Sun L; Freedland SJ
    BJU Int; 2010 Jun; 105(12):1654-9. PubMed ID: 19912203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do nomograms predict aggressive recurrence after radical prostatectomy more accurately than biochemical recurrence alone?
    Schroeck FR; Aronson WJ; Presti JC; Terris MK; Kane CJ; Amling CL; Freedland SJ
    BJU Int; 2009 Mar; 103(5):603-8. PubMed ID: 19021608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term cancer control outcomes in patients with biochemical recurrence and the impact of time from radical prostatectomy to biochemical recurrence.
    Pompe RS; Gild P; Karakiewicz PI; Bock LP; Schlomm T; Steuber T; Graefen M; Huland H; Tian Z; Tilki D
    Prostate; 2018 Jun; 78(9):676-681. PubMed ID: 29570821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of outcome following early salvage radiotherapy among patients with biochemical recurrence after radical prostatectomy.
    Briganti A; Karnes RJ; Joniau S; Boorjian SA; Cozzarini C; Gandaglia G; Hinkelbein W; Haustermans K; Tombal B; Shariat S; Sun M; Karakiewicz PI; Montorsi F; Van Poppel H; Wiegel T
    Eur Urol; 2014 Sep; 66(3):479-86. PubMed ID: 24345725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate-specific antigen level, stage or Gleason score: which is best for predicting outcomes after radical prostatectomy, and does it vary by the outcome being measured? Results from Shared Equal Access Regional Cancer Hospital database.
    Mithal P; Howard LE; Aronson WJ; Kane CJ; Cooperberg MR; Terris MK; Amling CL; Freedland SJ
    Int J Urol; 2015 Apr; 22(4):362-6. PubMed ID: 25728968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimum Tools for Predicting Clinical Outcomes in Prostate Cancer Patients Undergoing Radical Prostatectomy: A Systematic Review of Prognostic Accuracy and Validity.
    Campbell JM; Raymond E; O'Callaghan ME; Vincent AD; Beckmann KR; Roder D; Evans S; McNeil J; Millar J; Zalcberg J; Borg M; Moretti KL
    Clin Genitourin Cancer; 2017 Oct; 15(5):e827-e834. PubMed ID: 28666689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. External validation of preoperative nomograms predicting biochemical recurrence after radical prostatectomy.
    Tanaka A; Ohori M; Paul L; Yu C; Kattan MW; Ohno Y; Tachibana M
    Jpn J Clin Oncol; 2013 Dec; 43(12):1255-60. PubMed ID: 24146147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of international variation of prostate cancer on a predictive nomogram for biochemical recurrence in clinically localised prostate cancer.
    Cho YM; Jung SJ; Cho N; Kim MJ; Kattan MW; Yu C; Ahn H; Ro JY;
    World J Urol; 2014 Apr; 32(2):399-405. PubMed ID: 23765315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ability of 2 pretreatment risk assessment methods to predict prostate cancer recurrence after radical prostatectomy: data from CaPSURE.
    Mitchell JA; Cooperberg MR; Elkin EP; Lubeck DP; Mehta SS; Kane CJ; Carroll PR
    J Urol; 2005 Apr; 173(4):1126-31. PubMed ID: 15758720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A validation of two preoperative nomograms predicting recurrence following radical prostatectomy in a cohort of European men.
    Graefen M; Karakiewicz PI; Cagiannos I; Hammerer PG; Haese A; Palisaar J; Fernandez S; Noldus J; Erbersdobler A; Huland H; Scardino PT; Kattan MW
    Urol Oncol; 2002; 7(4):141-6. PubMed ID: 12474529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of three risk assessment tools in Australian patients with prostate cancer.
    Tamblyn DJ; Chopra S; Yu C; Kattan MW; Pinnock C; Kopsaftis T
    BJU Int; 2011 Nov; 108 Suppl 2():51-6. PubMed ID: 22085129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting survival of men with recurrent prostate cancer after radical prostatectomy.
    Dell'Oglio P; Suardi N; Boorjian SA; Fossati N; Gandaglia G; Tian Z; Moschini M; Capitanio U; Karakiewicz PI; Montorsi F; Karnes RJ; Briganti A
    Eur J Cancer; 2016 Feb; 54():27-34. PubMed ID: 26707594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positive surgical margins in radical prostatectomy patients do not predict long-term oncological outcomes: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) cohort.
    Mithal P; Howard LE; Aronson WJ; Terris MK; Cooperberg MR; Kane CJ; Amling C; Freedland SJ
    BJU Int; 2016 Feb; 117(2):244-8. PubMed ID: 26010160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incorporating artificial intelligence in urology: Supervised machine learning algorithms demonstrate comparative advantage over nomograms in predicting biochemical recurrence after prostatectomy.
    Tan YG; Fang AHS; Lim JKS; Khalid F; Chen K; Ho HSS; Yuen JSP; Huang HH; Tay KJ
    Prostate; 2022 Feb; 82(3):298-305. PubMed ID: 34855228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The CPC Risk Calculator: A New App to Predict Prostate-specific Antigen Recurrence During Follow-up After Radical Prostatectomy.
    Røder MA; Berg KD; Loft MD; Thomsen FB; Ferrari M; Kurbegovic S; Rytgaard HC; Gruschy L; Brasso K; Gerds TA; Kjær A; Brooks JD; Iversen P
    Eur Urol Focus; 2018 Apr; 4(3):360-368. PubMed ID: 28753827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Shared Equal Access Regional Cancer Hospital (SEARCH) nomogram for risk stratification in intermediate risk group of men with prostate cancer: validation in the Duke Prostate Center database.
    Jayachandran J; Schroeck F; Sun L; Gerber L; Moreira DM; Moul JW; Freedland SJ
    BJU Int; 2010 Jan; 105(2):180-4. PubMed ID: 19709074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.